Combined treatment of [Au(d2pype)2]Cl, a thioredoxin inhibitor, which targets a critical component of the cellular antioxidant system, with ibrutinib, a BTK inhibitor, induces apoptosis in DLBCL cells. The gene discussed is BTK; the disease is diffuse large B-cell lymphoma.